Andy Biotech Successfully Participates in CPHI Korea 2026 with Premium Plant Extract Solutions

Seoul, South Korea – August 27, 2026 – Andy Biotech, a professional manufacturer and supplier of high-purity plant extracts and natural bioactive ingredients, has concluded a successful exhibition at CPHI Korea 2026, one of the most influential professional exhibitions in the global pharmaceutical, nutraceutical and health ingredient industry. The three-day grand event was held at COEX Seoul from August 25 to August 27, where Andy Biotech showcased its star products at Booth K34, attracting extensive attention and in-depth consultations from numerous Korean local buyers, industry distributors and technical researchers.

As a pivotal platform connecting the Asian pharmaceutical and functional food markets, CPHI Korea 2026 gathered over 400 renowned exhibitors and tens of thousands of professional visitors from more than 80 countries and regions, covering the entire industrial chain of pharmaceutical raw materials, health ingredients and functional food additives. Leveraging this high-end industry platform, Andy Biotech fully displayed its core competitive product portfolio, including high-quality monk fruit extract, pomegranate extract, black rice extract and dihydroquercetin. All products adopt advanced extraction, purification and drying technologies, featuring high purity, stable quality, zero residue and excellent solubility, which are widely applicable in functional foods, dietary supplements, cosmetics and pharmaceutical health products.

During the exhibition, Andy Biotech’s professional sales and technical team provided one-on-one professional services for visiting Korean clients. The team conducted detailed introductions to product specifications, technical parameters, production processes, quality control standards and customized OEM/ODM solutions, while communicating in depth with clients on market application trends, product certification compliance and long-term cooperative modes.

The natural and healthy attributes of Andy Biotech’s plant extracts perfectly fit the current consumption trend of South Korea’s health and beauty industry, triggering continuous consultation enthusiasm from on-site clients. Many local Korean enterprises expressed strong intention for in-depth cooperation, reaching preliminary cooperation intentions on product sample testing, bulk procurement and regional agency distribution.

This participation in CPHI Korea 2026 has enabled Andy Biotech to deeply explore the South Korean and East Asian market, effectively enhance the brand’s local popularity and influence in the Korean pharmaceutical and health ingredient industry, and accumulate high-quality customer resources for subsequent regional market expansion.

In the future, Andy Biotech will continue to adhere to the development concept of "quality-oriented, innovation-driven", continuously optimize product technology and production system, strictly control product quality, and develop more high-value natural plant extract products that meet international market standards. The company will further deepen layout in the East Asian market, provide more professional and reliable raw material solutions for global customers, and strive to build a benchmark brand in the global natural ingredient industry.